News & Analysis as of September 19, 2024

Medicaid › Price-Fixing

+ Follow

Medicaid is a partnership program between states and the federal government to provide healthcare coverage for lower income individuals, people with disabilities, older people, and certain families with... more +

State AG Updates: Arizona, Texas, California, North Carolina, Washington, New York and an AG Coalition

Faegre Drinker Biddle & Reath LLP on 11/9/2022

In this edition of Faegre Drinker’s State Attorneys General Update, we discuss: • The Arizona AG’s $85 million settlement with Google relating to location-tracking data...more

State Attorneys General Updates From Arkansas, Washington, California & Texas

Faegre Drinker Biddle & Reath LLP on 2/15/2022

In this edition of Faegre Drinker’s State Attorneys General Update, we discuss: • A nearly $8 million settlement related to allegedly false Medicaid submissions in Arkansas - • Criminal charges filed under...more

Teva Pharma Charged with Antitrust Conspiracy in Generic Pharmaceuticals Industry

The Volkov Law Group on 9/1/2020

Teva, the global pharmaceutical giant, was indicted last week as part of DOJ’s expanding criminal conspiracy investigation focused on illegal price-fixing and customer allocations....more

White House Unveils Proposal on Drug Pricing

Holland & Knight LLP on 2/13/2018

On Feb. 9, 2018, the Trump Administration released a 30-page report analyzing domestic and global factors influencing drug pricing. The report by the Council of Economic Advisers (CEA) is expected to inform the HHS' Fiscal...more

Health Care Institutions

K&L Gates LLP on 12/30/2016

Originally published in Haig, Business and Commercial Litigation in Federal Courts, Fourth Edition §§ 87:1 et seq. © 2016 American Bar Association. This chapter discusses federal court litigation relating to health care...more

The Government’s Generic Price-Fixing Investigation Targets Allergan’s Actavis Unit

Patterson Belknap Webb & Tyler LLP on 8/19/2015

This is our fourth post on the DOJ’s expanding investigation into possible price fixing by generic drug manufacturers. (Click here, here, and here to read our prior posts.) Since our last update, the DOJ has subpoenaed...more

McKesson settles with Virginia for $37 million over allegations of inflating Medicaid drug prices

Akin Gump Strauss Hauer & Feld LLP on 10/23/2013

After the State of Virginia declined to participate in a July 2012 settlement that McKesson reached with 29 states over allegations of federal and various state False Claims Act violations, the company has agreed to pay...more

7 Results

View per page

Page: of 1